However, flavopiridola, an available cyclin D1 inhibitor [10,11] reserved the accelerated cell growth and the increased phosphorylation of pBb induced by CDKN2A knockdown in low-grade glioma cells (Figure 4B, C and Figure 5B). This evidence concerns the gene CDKN2A and central nervous system cancer.